Exercise-induced decrease in PHLPP-1 significantly stimulates cardiac hypertrophy through Akt, p70S6Kinase, and ERK, leading to a reduction in pathological hypertrophy, a reduction in cardiac apoptosis, and a reduction in infarct size. The gene discussed is MAPK1; the disease is cardiac hypertrophy.